| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 06.02.
| XOMA Up 6.0%, Shares Break Through Resistance | | 14 | SmarTrend |
| 31.01.
| Biotech Industry Rallies -- Arena Pharmaceuticals and XOMA Poised for Growth / Paragon Report Provides Equity Research on Arena Pharmaceuticals & XOMA Corporation | | 58 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 01/31/12 -- Biotechnology stocks have been on a tear this month, gaining an impressive 11 percent. Reuters recently released an article arguing health-care costs are...
Mehr lesen zu:
Biotech Industry Rallies -- Arena Pharmaceuticals and XOMA Poised for Growth / Paragon Report Provides Equity Research on Arena Pharmaceuticals & XOMA Corporation | |
| 26.01.
| Relatively Low Price to Forward Sales Detected in Shares of XOMA in the Biotechnology Industry | | 8 | SmarTrend |
| 25.01.
| Xoma's New Plans Bring Hesitant Hope | | 8 | Seeking Alpha |
| 19.01.
| XOMA Inks Deal with French Pharma | | 14 | Zacks |
| 18.01.
| Hot Stock: XOMA, Shares Gain 6.5% | | 9 | SmarTrend |
| 17.01.
| XOMA Corp. (XOMA) Acquires U.S. Perindopril Rihts from Les Laboratoires Servier | | 4 | StreetInsider.com |
| 13.01.
| Xoma Shares Down After Job Cuts and One Time Charges Announced | | 11 | Benzinga.com |
| 11.01.
| XOMA Up 11.3%, Shares Break Through Resistance | | 18 | SmarTrend |
| 09.01.
| Zalicus and Xoma Look for Strong Starts to 2012 / Five Star Equities Provides Stock Research on Zalicus & Xoma | | 41 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 01/09/12 -- Biotechnology stocks have performed well in the early stages of the New Year. Last Thursday, the NYSE Arca Biotechnology Index skyrocketed as much as 3 percent...
Mehr lesen zu:
Zalicus and Xoma Look for Strong Starts to 2012 / Five Star Equities Provides Stock Research on Zalicus & Xoma | |
| 05.01.
| UPDATE 1-XOMA to cut 34 pct jobs, sees charge in 2012 | | 11 | Reuters.com |
| 05.01.
| XOMA Streamlines Operations to Invest in Value-Creating Activities; Cuts 34% of Workforce | | 1 | Benzinga.com |
| 05.01.
| XOMA Corporation New CEO Says Company Expects to Initiate Global Gevokizumab Phase 3 Program in Q2 of 2012 | | 2 | Benzinga.com |
| 05.01.
| XOMA (XOMA) Announces Actions to Streamline Operations: Cutting 34% of Workforce, Sees One-Time Charge of $6M During 2012 | | 1 | StreetInsider.com |
| 05.01.
| XOMA (XOMA) to Streamline Operations: Cutting 84 Jobs, Sees Q1 Charge of $3.6M | | 2 | StreetInsider.com |
| 05.01.
| XOMA Appoints John Varian as Chief Executive Officer | | 3 | Benzinga.com |
| 02.01.
| XFRA FRA:New Instruments available on XETRA - 03.01.2012-001 | | 123 | Xetra Newsboard |
| The following instruments on XETRA do have their first trading day 03.01.2012 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag am 03.01.2012 TrdMod InstCode Exch ISIN Name InstGrp...
Mehr lesen zu:
XFRA FRA:New Instruments available on XETRA - 03.01.2012-001 | |
| 02.01.
| XFRA FRA: DELETION OF INSTRUMENTS FROM XETRA - 02.01.2012 | | 116 | Xetra Newsboard |
| The following instruments on XETRA do have their last trading day on 02.01.2012 Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 02.01.2012 ISIN Name BMG9825R2069 XOMA (BERM.) NEW...
Mehr lesen zu:
XFRA FRA: DELETION OF INSTRUMENTS FROM XETRA - 02.01.2012 | |
| 02.01.
| XFRA RQJA, XOMA, NV9A: AENDERUNG / CHANGE ISIN | | 95 | Xetra Newsboard |
| FUER FOLGENDE INSTRUMENTE WERDEN ISIN, WKN UND KUERZEL GEAENDERT. GUELTIG AB: 02.01.2012. FOR THE FOLLOWING INSTRUMENTS ISIN, WKN AND SHORT CODE WILL CHANGE. VALID FROM JANUARY 02, 2012. Einstellung...
Mehr lesen zu:
XFRA RQJA, XOMA, NV9A: AENDERUNG / CHANGE ISIN | |
| 30.12.
| XOMA Will Move Its Corporate Domicile to Delaware | | 3 | Benzinga.com |
